Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > MD Anderson trial post?

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Mar 31, 2021 4:23pm

69 Views

Post# 32916508

RE:RE:RE:RE:MD Anderson trial post?

It's a public information which should be disclosed to anyone with any interest. I didn't ask the question as TH's shareholder. There are folks out there following these trials for other reasons than financials for instance I have a niece with MS and I have been communicating with many organizations in charge of experimental research studies I wouldn't class that as harassment.

qwerty22 wrote:
You can do as you choose but I wouldn't endorse this sort of behaviour. shareholders pestering companies partners it's not really productive, I just don't think the partner is very going to appreciate it or think it's their role to deal with another companies shareholders.

scarlet1967 wrote: I am not concerned either but I send an inquiry to MD Anderson today if I get any response I let you know.

qwerty22 wrote:
I've been occasionally (regularly) looking at the MD Anderson trials website search. The th1902 trial hasn't appeared there yet, From my perspective it hasn't appeared then disappeared, it just hasn't yet gone to that searchable database. I could speculate a couple of reasons but basically I'm not too concerned atm. I think this is why the company hedged their bets on a Q2 start to the trial, sites each have to go thru paperwork to activate a site and I expect different sites do that to a different timetable, that's normal. Or it just could be they are slow to add the trial to the searchable database and it is active.

Here's where you search, I tried a few different searches and it doesn't appear.

https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials.html

As we know the trial is 'live' at the Penn site. I was also waiting for the clinicaltrials.gov page to get an update because that's still showing 'not recruiting', again ai'm not too concerned about either just a nice little re-assuring sign.

Wino115 wrote: I believe JFM or Qwerty were able to find the trial up on the MD Anderson trial website and posted the link. I couldn't find that old Stockhouse post. The lead investigator is Funda Meric-Bernstam; however, I was not able to find it anywhere on the MD Anderson site? Do you think THTX moved it over to someone else or a different facility? Perhaps something happened there. The clinicaltrials website still lists her as lead investigator but it hasn't been updated since January. Bit of a mystery.